AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Sanofi Board/Management Information 2016

Sep 6, 2016

1643_iss_2016-09-06_9576eadd-be58-49ba-9b61-0c35bf14b1ce.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Sanofi Board of Directors Provides Update

Paris, France - September 6, 2016 - Sanofi's Board of Directors was informed by Bonnie L. Bassler that she wished to resign as a Director of Sanofi due to a potential conflict of interest related to her impending membership on another board. Accordingly, her resignation was accepted, effective September 6th.

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Contacts:

Media Relations Laurence Bollack Tel. : +33 (0)1 53 77 46 46 [email protected]

Investor Relations George Grofik Tel.: +33 (0)1 53 77 45 45 [email protected]